Imaging and biomarkers in early alzheimer's disease and mild cognitive impairment

R. C. Petersen; C. R. Jack

doi:10.1038/clpt.2009.166

Imaging and biomarkers in early alzheimer's disease and mild cognitive impairment

R. C. Petersen, C. R. Jack

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Abstract

A major focus of research on aging and dementia pertains to the prediction of future cognitive decline. Toward this end, several longitudinal studies are under way that are designed to explore early predictors of cognitive impairment. Neuroimaging techniques and biomarkers have shown promise in this application. Ultimately, it is likely that the use of a combination of neuroimaging and chemical biomarkers will be involved in predicting the development of dementia and Alzheimer's disease (AD).

Original language	English (US)
Pages (from-to)	438-441
Number of pages	4
Journal	Clinical pharmacology and therapeutics
Volume	86
Issue number	4
DOIs	https://doi.org/10.1038/clpt.2009.166
State	Published - Oct 2009

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1038/clpt.2009.166

Cite this

@article{639a6c4a962c42f08685171bf6572f30,

title = "Imaging and biomarkers in early alzheimer's disease and mild cognitive impairment",

abstract = "A major focus of research on aging and dementia pertains to the prediction of future cognitive decline. Toward this end, several longitudinal studies are under way that are designed to explore early predictors of cognitive impairment. Neuroimaging techniques and biomarkers have shown promise in this application. Ultimately, it is likely that the use of a combination of neuroimaging and chemical biomarkers will be involved in predicting the development of dementia and Alzheimer's disease (AD).",

author = "Petersen, {R. C.} and Jack, {C. R.}",

year = "2009",

month = oct,

doi = "10.1038/clpt.2009.166",

language = "English (US)",

volume = "86",

pages = "438--441",

journal = "Clinical pharmacology and therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Imaging and biomarkers in early alzheimer's disease and mild cognitive impairment

AU - Petersen, R. C.

AU - Jack, C. R.

PY - 2009/10

Y1 - 2009/10

N2 - A major focus of research on aging and dementia pertains to the prediction of future cognitive decline. Toward this end, several longitudinal studies are under way that are designed to explore early predictors of cognitive impairment. Neuroimaging techniques and biomarkers have shown promise in this application. Ultimately, it is likely that the use of a combination of neuroimaging and chemical biomarkers will be involved in predicting the development of dementia and Alzheimer's disease (AD).

AB - A major focus of research on aging and dementia pertains to the prediction of future cognitive decline. Toward this end, several longitudinal studies are under way that are designed to explore early predictors of cognitive impairment. Neuroimaging techniques and biomarkers have shown promise in this application. Ultimately, it is likely that the use of a combination of neuroimaging and chemical biomarkers will be involved in predicting the development of dementia and Alzheimer's disease (AD).

UR - http://www.scopus.com/inward/record.url?scp=70349446475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349446475&partnerID=8YFLogxK

U2 - 10.1038/clpt.2009.166

DO - 10.1038/clpt.2009.166

M3 - Article

C2 - 19710641

AN - SCOPUS:70349446475

SN - 0009-9236

VL - 86

SP - 438

EP - 441

JO - Clinical pharmacology and therapeutics

JF - Clinical pharmacology and therapeutics

IS - 4

ER -

Imaging and biomarkers in early alzheimer's disease and mild cognitive impairment

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this